Literature DB >> 34100737

Unsolved issues of The Efficacy and Safety of Edoxaban.

Leszek Drabik1, Anetta Undas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34100737      PMCID： PMC8210933          DOI： 10.5152/AnatolJCardiol.2021.81410

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  5 in total

1.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

2.  The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis.

Authors:  Xiangwen Liang; Wenchao Xie; Zhihai Lin; Ming Liu
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

3.  Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.

Authors:  Junyu Chen; Xiaodong Zhuang; Ming Long; Chen Su; Lichun Wang
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-08-29       Impact factor: 2.136

4.  Trends in antithrombotic management of patients with atrial fibrillation. A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry.

Authors:  Piotr Lodziński; Monika Gawałko; Monika Budnik; Agata Tymińska; Krzysztof Ozierański; Marcin Grabowski; Agnieszka Janion-Sadowska; Grzegorz Opolski; Radosław Lenarczyk; Zbigniew Kalarus; Gregory Y H Lip; Paweł Balsam
Journal:  Pol Arch Intern Med       Date:  2020-01-24

Review 5.  Bleeding in anticoagulated patients with atrial fibrillation: practical considerations.

Authors:  Anetta Undas; Leszek Drabik; Tatjana Potpara
Journal:  Pol Arch Intern Med       Date:  2020-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.